A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis
Clinical trial NCT06433999 · COMPLETED
Trial details
- NCT number
- NCT06433999
- Sponsor
- Priovant Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-28
- Primary completion
- 2025-02-28
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.